This was the stock's fourth consecutive day of gains.

Shares of Abbott Laboratories (NYSE:ABT) and DexCom (NASDAQ:DXCM) traded higher on Tuesday after Secretary of the U.S.

A whistleblower’s False Claims Act suit filed in 2021 alleging fraudulent diabetic supplies billing by Arriva Medical LLC, ...

Illinois-based Abbott Laboratories required job applicants to disclose their family medical histories in violation of the state’s Genetic Information Privacy Act, a proposed federal class action said.

Abbott Laboratories (NYSE: ABT) is one of the 17 stocks that Jim Cramer commented on. During the episode, Cramer was bullish ...

Shares of Abbott Laboratories ABT slipped 1.29% to $132.28 Tuesday, on what proved to be an all-around dismal trading session ...